Diagnosing Subgroup Stability of Model-Based Label Statements

What Does Subgroup Stability Mean?

A model-derived label statement is not automatically supported for every patient group merely because it is supported in the overall population. A statement such as “the recommended regimen keeps exposure within the target range” or “the event risk remains below a specified threshold” makes a claim about a defined quantity, population, and decision criterion. Subgroup stability asks whether the evidence supporting that particular claim remains adequate in clinically relevant groups.

Stability does not mean that every subgroup estimate must be identical. Small differences can be clinically unimportant, and estimates can vary because of sampling uncertainty. Conversely, an interaction test that is not statistically significant does not establish that a claim holds in all groups: a subgroup estimate may be too imprecise to rule out clinically important failure. The assessment must therefore connect three things: the subgroup contrast or prediction, its uncertainty, and the criterion stated or implied by the claim.

Definition: A model-derived label statement is subgroup-stable under a specified criterion when the relevant model-based estimand satisfies that criterion, with an uncertainty assessment adequate for the intended interpretation, in each prespecified clinically relevant subgroup. Stability is specific to the claim, estimand, subgroups, model, and decision criterion; it is not a general assertion that subgroup effects are equal.

Begin by making the statement operational. Identify the outcome or exposure quantity, the comparison or regimen, the time point, the subgroup definitions, and the threshold or clinically acceptable range. Then determine whether the question concerns a difference between groups (an interaction) or whether each group separately satisfies a target. These are related but distinct questions.

Interactions and Subgroup-Specific Contrasts

For a binary subgroup indicator \(G\), a model with treatment or regimen indicator \(T\) and a treatment-by-subgroup interaction can be written on the model scale as

\eta = \beta_0+\beta_T T+\beta_G G+\beta_{TG}(T G).

Here \(\eta\) is the modeled outcome or linear predictor. When \(T=0\) is the reference regimen, the modeled contrast for \(T=1\) versus \(T=0\) is \(\beta_T\) in \(G=0\), and \(\beta_T+\beta_{TG}\) in \(G=1\). Thus \(\beta_{TG}\) is the difference between the two subgroup contrasts on the model scale. With a log link, exponentiating the interaction gives a ratio of the two subgroup-specific ratios; with a logit link, the interaction is a difference in log odds contrasts, not generally a difference in probabilities.

A subgroup contrast that adds coefficients must include their covariance when its uncertainty is calculated. The variance identity follows from \(\operatorname{Var}(A+B)=\operatorname{Var}(A)+\operatorname{Var}(B)+2\operatorname{Cov}(A,B)\). Consequently,

SE(\hat{\beta}_T+\hat{\beta}_{TG}) = \sqrt{SE(\hat{\beta}_T)^2+SE(\hat{\beta}_{TG})^2+ 2\operatorname{Cov}(\hat{\beta}_T,\hat{\beta}_{TG})}.

Ignoring the covariance can either overstate or understate uncertainty. For nonlinear models, the subgroup prediction on the response scale is obtained by applying the inverse link to the linear predictor. A confidence interval formed on the linear-predictor scale can be transformed endpoint by endpoint, provided the interval and model are appropriate for that prediction.

Worked Example: Comparing Exposure Ratios Across Two Subgroups

Hypothetical model output. Let \(Z\) be log exposure, so that the contrast between regimens on the \(Z\) scale is a log exposure ratio. Suppose \(G=0\) and \(G=1\) denote two clinically relevant subgroups and \(T=1\) denotes the label regimen, with \(T=0\) the reference regimen. The fitted model is \(Z=\beta_0+\beta_TT+\beta_GG+\beta_{TG}(TG)\). Assume estimates \(\hat{\beta}_T=-0.120\), \(SE(\hat{\beta}_T)=0.040\), \(\hat{\beta}_{TG}=0.030\), \(SE(\hat{\beta}_{TG})=0.050\), and \(\operatorname{Cov}(\hat{\beta}_T,\hat{\beta}_{TG})=0.000200\). These are hypothetical estimates, with exposure expressed in consistent units before taking logs.

In \(G=0\), the log exposure ratio is \(-0.120\), so the estimated exposure ratio is \(e^{-0.120}=0.887\). Its approximate 95% confidence interval on the log scale is \[ -0.120\pm1.96(0.040)=[-0.1984,-0.04160]. \] Exponentiating both endpoints gives an exposure-ratio interval of approximately \([0.8200,0.9593]\).

In \(G=1\), the log exposure ratio is \(-0.120+0.030=-0.0900\), giving an estimated ratio \(e^{-0.0900}=0.9139\). Its standard error is \[ \sqrt{0.040^2+0.050^2+2(0.000200)} =\sqrt{0.004500}=0.06708. \] The approximate 95% interval on the log scale is \(-0.0900\pm1.96(0.06708)=[-0.2215,0.04148]\). Exponentiation gives approximately \([0.8013,1.042]\).

The interaction estimate is \(0.0300\), with standard error \(0.0500\). Its approximate 95% interval is \(0.0300\pm1.96(0.0500)=[-0.06800,0.1280]\). Exponentiating gives a ratio of subgroup exposure ratios of \(1.030\), with interval approximately \([0.9343,1.137]\). The interval includes 1, so these results do not show a clear difference in exposure-ratio effects between subgroups. That is not proof of equality.

Suppose the prespecified acceptable exposure-ratio range is 0.80 to 1.25 in each subgroup. Both subgroup intervals lie within that range, although the lower endpoint for \(G=1\) is close to 0.80. Under a decision rule requiring each approximate 95% interval to be within the range, the model output supports the statement in both subgroups, subject to the model’s assumptions and the appropriateness of that interval-based rule. The interaction interval answers a different question: whether the subgroup contrasts differ.

Evaluate the Claim, Not Just the Interaction Test

An interaction test asks whether the estimated subgroup contrasts differ from one another on a specified model scale. A label claim often asks whether each subgroup’s prediction meets a target. A small interaction estimate can coexist with uncertainty too wide to support the target in a subgroup. A detectable interaction can also occur while every subgroup remains comfortably within a clinically acceptable range. Therefore, neither the interaction estimate nor its p-value alone determines stability.

For a probability claim, calculate and assess subgroup-specific probabilities on the response scale. The following example uses a logistic model and shows why a point prediction below a threshold may not provide adequate support for a threshold-based statement.

Worked Example: A Subgroup Risk Threshold

Hypothetical model output. Suppose the model is \(\operatorname{logit}(p)=\eta\), where \(p\) is the probability of a specified event at the label regimen and time point. The predicted linear predictors are \(\hat{\eta}_0=-2.900\) with standard error \(0.200\) for \(G=0\), and \(\hat{\eta}_1=-1.900\) with standard error \(0.300\) for \(G=1\). Assume the model is appropriately specified for these groups and that the reported standard errors account for the fitted model’s uncertainty. The label-related criterion is that event risk be below 15% in each subgroup.

For \(G=0\), the predicted risk is \[ \hat{p}_0=\frac{1}{1+e^{2.900}}=0.0522, \] or 5.22%. The approximate 95% interval on the linear-predictor scale is \(-2.900\pm1.96(0.200)=[-3.292,-2.508]\). Transforming its endpoints through the logistic function gives an approximate probability interval \([0.0358,0.0753]\), or 3.58% to 7.53%. Its upper endpoint is below 15%.

For \(G=1\), the predicted risk is \[ \hat{p}_1=\frac{1}{1+e^{1.900}}=0.130, \] or 13.0%. The linear-predictor interval is \(-1.900\pm1.96(0.300)=[-2.488,-1.312]\). Transforming the endpoints gives approximately \([0.0767,0.212]\), or 7.67% to 21.2%. Although the point prediction is below 15%, the interval extends above the threshold. Under a rule requiring the upper confidence limit to be below 15% in every subgroup, the model supports the threshold claim for \(G=0\), but does not provide the same level of support for \(G=1\). This does not establish that the true risk in \(G=1\) exceeds 15%; it indicates that the stated criterion is not demonstrated with this uncertainty.

Check Precision and Clinical Relevance Together

Subgroup estimates can be unstable because data are limited or unevenly distributed. An interaction estimate may be imprecise even when each subgroup prediction appears plausible, and a subgroup prediction may be imprecise even when the interaction is near zero. Review the uncertainty for the exact estimand behind the claim, rather than relying on the precision of a related model coefficient.

The following example illustrates the difference between a subgroup point estimate, its uncertainty, and an interaction estimate. Assume the subgroup estimates come from separate, independent samples and use a normal approximation. In an actual analysis, covariance or the fitted model’s full variance calculation should be used when estimates are not independent.

Worked Example: A Minimum Benefit Claim With Unequal Precision

Hypothetical estimates. Suppose a model estimates treatment effects on a symptom-change scale, in points, as \(-4.00\) points in subgroup A with standard error \(1.00\), and \(-2.50\) points in subgroup B with standard error \(1.40\). Negative values indicate symptom reduction. Consider a claim that the mean reduction is at least 2 points in each subgroup, meaning that each treatment contrast should be \(-2\) points or lower.

The approximate 95% interval in A is \(-4.00\pm1.96(1.00)=[-5.96,-2.04]\) points. This interval lies below \(-2\), so A meets the chosen interval-based criterion. In B, the interval is \(-2.50\pm1.96(1.40)=[-5.244,0.244]\) points. The point estimate meets the criterion, but the interval does not; it includes effects smaller than the claimed 2-point reduction and even a small positive effect.

The estimated interaction, defined as the B effect minus the A effect, is \(-2.50-(-4.00)=1.50\) points. Under the stated independence assumption, its standard error is \[ \sqrt{1.00^2+1.40^2}=\sqrt{2.96}=1.720\text{ points}. \] The approximate 95% interaction interval is \(1.50\pm1.96\sqrt{2.96}=[-1.872,4.872]\) points. This interval is broad and includes zero, so it does not establish a subgroup difference. Yet the uncertainty in B still prevents the minimum-benefit claim from meeting the specified criterion there. The example shows why “no significant interaction” is not a sufficient subgroup-stability conclusion.

Diagnostics, Alternatives, and Limitations

Before interpreting a subgroup result, check whether the model can credibly make the prediction being used. The earlier material on model structure and assumptions applies: a prediction is only as reliable as its outcome model, covariate structure, and data support. For subgroup stability, pay particular attention to the following:

Definition and estimand: Confirm that subgroup boundaries, outcome, regimen contrast, time point, and clinical criterion match the wording of the claim. Changing any of these can change the conclusion.
Data support and overlap: Check sample sizes, event counts, covariate ranges, and representation of both regimens within each subgroup. Predictions far outside the observed covariate support are extrapolations, not reassuring evidence of stability.
Model fit and influential observations: Examine residual patterns, calibration or predictive performance as appropriate to the outcome, and whether a small number of observations drive an interaction or subgroup prediction. Sparse events can make risk estimates especially fragile.
Uncertainty calculation: Verify that coefficient covariance is included for combined contrasts and that the interval is on the correct scale before transformation. A narrow interval for an interaction does not substitute for the uncertainty interval of each subgroup prediction.
Multiplicity and subgroup selection: If many subgroups were examined and only the most favorable are reported, apparent stability can be misleading. Prespecify clinically meaningful subgroups where possible and describe exploratory analyses as such.

A pooled model with an interaction often provides a direct estimate of subgroup contrast differences while retaining a common model structure. Separate subgroup fits are an alternative when the scientific model genuinely differs by subgroup, but they can be less precise, may use inconsistent assumptions, and make direct comparisons harder. A pooled model without an interaction is more parsimonious but imposes a common contrast; that restriction should be justified rather than assumed because an interaction test was not significant. Standardized subgroup predictions can be useful when covariate distributions differ, but the target covariate distribution must be stated because the resulting estimand depends on it.

No single interval rule fits every label claim. Requiring a confidence interval to lie wholly within an acceptable range is a conservative criterion for demonstrating compatibility with that range; it is not the only possible decision rule. The uncertainty measure, confidence level, and margin should be selected to match the regulatory and clinical question. Model uncertainty may also be understated if the fitted model treats structural choices as fixed. Finally, a stable prediction under one model does not guarantee stability under plausible alternative structures or in populations poorly represented by the supporting data.

Common pitfall: “The treatment-by-subgroup interaction was not statistically significant, so the label statement applies equally to both groups.” This reasoning confuses failure to detect a difference with evidence that subgroup effects are sufficiently similar, and it ignores whether each subgroup meets the claim’s own threshold. Instead, report the interaction estimate and uncertainty, calculate the relevant subgroup predictions and uncertainty, and judge each against a prespecified clinically meaningful criterion.

Specify the claim.
State the estimand, regimen or comparison, outcome scale, time point, subgroup definitions, and threshold or acceptable range.

Calculate subgroup results.
Use the fitted model to obtain each subgroup contrast or prediction and its uncertainty, including covariance for combined coefficients.

Assess the interaction and the claim separately.
Interpret the interaction on its model scale, then check whether each subgroup estimate meets the claim-specific criterion.

Check credibility and communicate limits.
Review data support, model fit, extrapolation, and multiplicity; state where evidence supports, does not support, or remains inconclusive for the claim.

Check Your Understanding

Answer each question using the distinction between subgroup differences and subgroup-specific support.

A treatment-by-subgroup interaction has an estimate near zero and a wide confidence interval. Does this establish that the treatment effects are equal?
A predicted event risk is below a label threshold in a subgroup, but its confidence interval crosses that threshold. What conclusion is justified?
In a model with a log-exposure outcome, what does the exponentiated treatment-by-subgroup interaction represent?
Why must covariance be included when calculating the standard error of a subgroup contrast that adds two fitted coefficients?

Solutions. (1) No. A wide interval is compatible with potentially important differences; absence of detected interaction is not evidence of equality. (2) The point prediction is below the threshold, but the uncertainty does not rule out a value above it, so a criterion requiring the interval to remain below the threshold is not met. This does not prove that the true risk exceeds the threshold. (3) It is the ratio of the subgroup-specific exposure ratios, because the interaction is the difference between log exposure contrasts and exponentiation converts that difference to a ratio. (4) For coefficients \(A\) and \(B\), \(\operatorname{Var}(A+B)=\operatorname{Var}(A)+\operatorname{Var}(B)+2\operatorname{Cov}(A,B)\); omitting the covariance can give the wrong uncertainty.